Aspire Private Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-126
| Closed | -$19.6K | – | 202 |
|
|
2024
Q3 | $19.6K | Hold |
126
| – | – | ﹤0.01% | 306 |
|
|
2024
Q2 | $19.6K | Hold |
126
| – | – | 0.01% | 317 |
|
|
2024
Q1 | $17K | Hold |
126
| – | – | ﹤0.01% | 340 |
|
|
2023
Q4 | $16.9K | Hold |
126
| – | – | 0.01% | 340 |
|
|
2023
Q3 | $17K | Hold |
126
| – | – | 0.01% | 334 |
|
|
2023
Q2 | $18K | Hold |
126
| – | – | 0.01% | 303 |
|
|
2023
Q1 | $17.5K | Sell |
126
-2
| -2% | -$269 | 0.01% | 301 |
|
|
2022
Q4 | $17.4K | Hold |
128
| – | – | 0.01% | 307 |
|
|
2022
Q3 | $14K | Sell |
128
-1
| -0.8% | -$127 | 0.01% | 308 |
|
|
2022
Q2 | $17K | Hold |
129
| – | – | 0.01% | 288 |
|
|
2022
Q1 | $17K | Hold |
129
| – | – | 0.01% | 295 |
|
|
2021
Q4 | $15K | Sell |
129
-2
| -2% | -$235 | ﹤0.01% | 300 |
|
|
2021
Q3 | $16K | Buy |
131
+27
| +26% | +$3.14K | 0.01% | 280 |
|
|
2021
Q2 | $12K | Hold |
104
| – | – | ﹤0.01% | 306 |
|
|
2021
Q1 | $10K | Hold |
104
| – | – | ﹤0.01% | 328 |
|
|
2020
Q4 | $10K | Hold |
104
| – | – | ﹤0.01% | 266 |
|
|
2020
Q3 | $11K | Buy |
+104
| New | +$11.6K | ﹤0.01% | 269 |
|
|
2020
Q2 | – | Sell |
-4
| Closed | – | – | 297 |
|
|
2020
Q1 | $0 | Sell |
4
-114
| -97% | -$10.7K | ﹤0.01% | 250 |
|
|
2019
Q4 | $12K | Buy |
118
+4
| +4% | +$377 | 0.01% | 254 |
|
|
2019
Q3 | $10K | Hold |
114
| – | – | ﹤0.01% | 251 |
|
|
2019
Q2 | $9K | Buy |
114
+10
| +10% | +$784 | ﹤0.01% | 274 |
|
|
2019
Q1 | $8K | Sell |
104
-3,690
| -97% | -$291K | ﹤0.01% | 328 |
|
|
2018
Q4 | $288K | Buy |
+3,794
| New | +$296K | 0.17% | 100 |
|
Other funds holding AZN
